Patent · US Active

Vaccines with CD40 ligand as an adjuvant

US10925961B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignees

The Trustees of the University of Pennsylvania · US
Inovio Pharmaceuticals, Inc. · US

Inventors

David B. Weiner · Yeadon, US
Matthew P. Morrow · Yeadon, US
Megan Wise · Raleigh, US

Key dates

Filing date	Mar 18, 2016
Grant date	Feb 23, 2021
Priority date	—
Expiry date	Jan 28, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is a vaccine comprising an antigen and CD40L. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.